This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

Our News

FDA Lifts Restrictions on Spinal Cord Stimulation System

By Admin | January 22, 2022

The US Food and Drug Administration (FDA) has approved updated labeling that expands MRI compatibility for Abbot’s Proclaim XR spinal cord stimulation (SCS) system, the company announced.

The FDA originally approved the Proclaim XR neurostimulation system for patients with chronic pain in 2019, as reported at the time by Medscape Medical News...(More)

For more info please read, FDA Lifts Restrictions on Spinal Cord Stimulation System, by Medscape

« Return to ALL NEWS

Only at Axis

We require 100 hours each year of continuing education for our clinical team.

How We Operate

As the credentialing coordinator, there are many times when the department is called upon to ensure a tech and reader are admitted to a hospital in order to assist a surgeon with a last-minute surgical case. By providing required documents in a timely manner, the patient benefits in the end by receiving the best possible care. This follows the Axis Mission Statement of ‘Patient First’.